Tenax Therapeutics, Inc

(NASDAQ:TENX)

Latest On Tenax Therapeutics, Inc (TENX):

Date/Time Type Description Signal Details
2023-03-08 01:11 ESTNewsTenax Therapeutics a buy at RothMKM due to late-stage pulmonary hypertension assetsN/A
2023-02-03 13:15 ESTNewsTenax Therapeutics stock dips after pricing $15.6M securities offeringN/A
2023-02-03 00:10 ESTNewsTenax stock surges ~65% on upcoming US patent linked to heart disease therapyN/A
2023-01-04 10:45 ESTNewsTenax Therapeutics to execute 1-for-20 reverse stock splitN/A
2022-09-15 22:59 ESTNewsTenax to evaluate strategic alternatives including a sale or a merger, shares rise ~7%N/A
2022-05-18 14:28 ESTNewsTenax therapeutics announces $8M PIPE offeringN/A
2022-03-31 19:21 ESTNewsTenax Therapeutics GAAP EPS of -$1.58 misses by $1.51N/A
2022-01-12 11:35 ESTNewsTenax Therapeutics nabs new U.S. patent for the subcutaneous use of levosimendanN/A
2021-11-17 04:36 ESTNewsTenax Therapeutics EPS misses by $0.02N/A
2021-10-28 03:47 ESTNewsWarning: TENX is at high risk of performing badlyN/A
2021-08-13 01:23 ESTNewsTenax's highlights levosimendan mechanism in cardiovascular diseasesN/A
2021-07-22 03:26 ESTNewsTenax Therapeutics reports retirement of CEO and $10M PIPE financingN/A
2021-04-09 11:18 ESTNewsTenax levosimendan improves hemodynamics, exercise tolerance in cardio-pulmonary diseasesN/A
2021-04-07 22:21 ESTNewsTenax Therapeutics chairman to retireN/A
2021-04-01 04:46 ESTNewsTenax Therapeutics EPS misses by $0.49N/A
2021-02-15 12:29 ESTAnalyst RatingThe Analyst Target Price has increased from $3.67 to $4.5.Buy
2021-01-19 18:14 ESTNewsTenax Therapeutics acquires PH Precision MedN/A
2020-12-30 12:50 ESTAnalyst RatingThe Analyst Target Price has increased from $3 to $3.67.Buy
2020-11-26 21:45 ESTFinancialsCompany financials have been released.Neutral
2020-11-20 13:05 ESTAnalyst RatingThe Analyst Target Price has decreased from $4.22 to $3.Neutral
2020-11-17 21:23 ESTFinancialsCompany financials have been released.Neutral
2020-11-17 20:57 ESTNewsTenax Therapeutics EPS misses by $0.04N/A
2020-11-17 12:55 ESTEarnings EstimateAn EPS average of -$0.29 is estimated for the quarter ending on March 31, 2021.Sell
2020-11-14 12:39 ESTNewsAcceleron's sotatercept shows positive action in mid-stage pulmonary arterial hypertension studiesN/A
2020-11-08 01:03 ESTFinancialsCompany financials have been released.Neutral
2020-11-07 17:18 ESTFinancialsCompany financials have been released.Neutral
2020-10-16 03:34 ESTNewsTenax Therapeutics gains North American rights to oral levosimendan; shares +14%N/A
2020-09-26 14:12 ESTFinancialsCompany financials have been released.Neutral
2020-09-17 06:24 ESTFinancialsCompany financials have been released.Neutral
2020-09-09 19:28 ESTInsider TradeARMISTICE CAPITAL, LLC has indirectly acquired of 0 shares.Buy
2020-09-09 19:28 ESTInsider TradeARMISTICE CAPITAL, LLC has directly acquired 8,543 shares and currently holds 2,019,995 shares.Buy
2020-09-09 19:28 ESTInsider TradeARMISTICE CAPITAL, LLC has indirectly acquired of 0 shares.Buy
2020-09-09 19:28 ESTInsider TradeARMISTICE CAPITAL, LLC has directly acquired 23,457 shares and currently holds 2,011,452 shares.Buy
2020-09-03 18:04 ESTInsider TradeARMISTICE CAPITAL, LLC has directly acquired 36,000 shares and currently holds 1,987,995 shares.Buy
2020-09-03 18:04 ESTInsider TradeARMISTICE CAPITAL, LLC has indirectly acquired of 0 shares.Buy
2020-09-03 18:04 ESTInsider TradeARMISTICE CAPITAL, LLC has indirectly acquired of 0 shares.Buy
2020-09-03 18:04 ESTInsider TradeARMISTICE CAPITAL, LLC has directly acquired 20,000 shares and currently holds 1,951,995 shares.Buy
2020-09-03 18:04 ESTInsider TradeARMISTICE CAPITAL, LLC has directly acquired 30,000 shares and currently holds 1,931,995 shares.Buy
2020-09-03 18:04 ESTInsider TradeARMISTICE CAPITAL, LLC has indirectly acquired of 0 shares.Buy
2020-08-31 19:45 ESTInsider TradeARMISTICE CAPITAL, LLC has indirectly acquired of 0 shares.Buy
2020-08-31 19:45 ESTInsider TradeARMISTICE CAPITAL, LLC has directly acquired 20,000 shares and currently holds 1,901,995 shares.Buy
2020-08-31 19:45 ESTInsider TradeARMISTICE CAPITAL, LLC has indirectly acquired of 0 shares.Buy
2020-08-31 19:45 ESTInsider TradeARMISTICE CAPITAL, LLC has directly acquired 12,000 shares and currently holds 1,881,995 shares.Buy
2020-08-27 09:44 ESTAnalyst RatingThe Analyst Target Price has decreased from $5.47 to $4.22.Neutral
2020-08-26 18:15 ESTInsider TradeARMISTICE CAPITAL, LLC has indirectly acquired of 0 shares.Buy
2020-08-26 18:15 ESTInsider TradeARMISTICE CAPITAL, LLC has directly acquired 12,000 shares and currently holds 1,869,995 shares.Buy
2020-08-26 18:15 ESTInsider TradeARMISTICE CAPITAL, LLC has indirectly acquired of 0 shares.Buy
2020-08-26 18:15 ESTInsider TradeARMISTICE CAPITAL, LLC has directly acquired 17,211 shares and currently holds 1,857,995 shares.Buy
2020-08-26 18:15 ESTInsider TradeARMISTICE CAPITAL, LLC has indirectly acquired of 0 shares.Buy
2020-08-26 18:15 ESTInsider TradeARMISTICE CAPITAL, LLC has directly acquired 5,692 shares and currently holds 1,840,784 shares.Buy

About Tenax Therapeutics, Inc (TENX):

Tenax Therapeutics, Inc., a specialty pharmaceutical company, focuses on identifying, developing, and commercializing products for cardiovascular and pulmonary diseases in the United States and Canada. The company focuses on the development and commercialization of pharmaceutical products containing levosimendan, 2.5 mg/ml concentrate for solution for infusion/5ml vial for use in the reduction of morbidity and mortality in cardiac surgery patients at risk for developing low cardiac output syndrome. It is also involved in initiating a Phase 2 clinical trial of levosimendan for the treatment of patients with pulmonary hypertension associated with heart failure with preserved ejection fraction. The company was formerly known as Oxygen Biotherapeutics, Inc. and changed its name to Tenax Therapeutics, Inc. in September 2014. Tenax Therapeutics, Inc. was founded in 1967 and is headquartered in Morrisville, North Carolina.

See Advanced Chart

General

  • Name Tenax Therapeutics, Inc
  • Symbol TENX
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 9
  • Last Split Factor1:20
  • Last Split Date2018-02-26
  • Fiscal Year EndDecember
  • IPO Date1997-01-02
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://www.tenaxthera.com
View More

Valuation

  • Forward PE 16.21
  • Price/Book (Most Recent Quarter) 4.45
  • Enterprise Value EBITDA 0.07
View More

Financials

  • Most Recent Quarter 2020-09-30
  • Next Quarter EPS Estimate -$0.13
  • Return on Assets -73%
  • Return on Equity -141%
  • Earnings Per Share -$3.95
  • Revenue Per Share $0
  • Quarterly Earnings Growth 0%
View More

Highlights

  • Market Capitalization 31.2 million
  • EBITDA -7226812
  • Analyst Target Price $4.5
  • Book Value Per Share $0.59
View More

Share Statistics

  • Shares Outstanding 14.51 million
  • Shares Float 10.25 million
  • % Held by Insiders 33%
  • % Held by Institutions 32.15%
  • Shares Short 569417
  • Shares Short Prior Month 576087
  • Short Ratio 0.46
  • Short % of Float 4%
  • Short % of Shares Outstanding 4%
View More

Technicals

  • Beta 2.35
  • 52 Week High $3.68
  • 52 Week Low $0.45
  • 50 Day Moving Average 2.37
  • 200 Day Moving Average 1.63
View More

Dividends

  • Dividend Date 2018-02-26
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Tenax Therapeutics, Inc (TENX) Dividend Calendar:

TENX's last dividend payment was made to shareholders on February 26, 2018.

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Tenax Therapeutics, Inc (TENX) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-09-302020-11-16$N/A-$0.18-$0.15-24.14%
2020-06-302020-08-14$N/A-$0.23-$0.21-9.52%
2020-03-312020-05-15$N/A-$0.38-$0.19-100%
2019-12-312020-03-30$N/A-$0.42-$0.6130.58%
2019-09-302019-11-14$N/A-$0.33-$0.379.59%
2019-06-302019-08-14$N/A-$0.28-$0.4537.78%
2019-03-312019-05-15$N/A-$0.33-$0.342.94%
2018-12-312019-03-31$N/A-$5.87-$0.31-1793.87%
2018-09-302018-11-14$N/A-$1.05-$1.4628.08%
2018-06-302018-08-14$N/A-$1.29-$1.4510.73%
2018-03-312018-05-15$N/A-$0.83-$1.3136.64%
2017-12-312018-03-20$N/A-$0.95-$1.0711.05%
2017-09-302017-11-09$N/A-$0.80-$1.1027.27%
2017-06-302017-08-09$N/A-$2.20-$1.80-22.22%
2017-03-312017-05-10$N/A-$2.40-$2.00-20%
2016-12-312017-03-16$N/A-$21.00-$2.80-650%
2016-09-302016-11-09$N/A-$3.00-$3.309.09%
2016-06-302016-08-09$N/A-$3.40-$3.400%
2016-03-312016-05-10$N/A-$3.80-$2.73-39.03%
2015-09-302015-12-10$N/A-$2.60-$2.703.7%
2015-06-302015-07-14$49286-$2.80-$2.70-3.7%
2014-12-312015-03-17$N/A-$2.00-$3.1336.1%
2014-09-302014-12-15$N/A-$2.80-$3.5020%
2014-06-302014-07-29$N/A-$2.60-$7.6065.79%
2014-03-312014-04-02$104449-$8.74
2013-12-312014-03-17$41864-$8.60-$3.60-138.89%
2013-09-302013-10-02$59000-$67.14
2013-03-312013-04-30$181572-$34.14
2012-12-312013-01-31$224000-$55.54
2012-09-302012-10-31$524000-$52.48
2012-06-302012-07-31$278000-$86.07
2012-03-312012-04-30$120360-$31.34
2011-12-312012-01-31$151000-$155.48
2011-09-302011-10-31$95159-$116.50
2011-06-302011-07-14$59000-$40.00-$40.000%
2011-03-312011-04-30$226000-$48.83
2010-12-312011-03-21$53000-$44.00-$40.00-10%
2010-09-302010-12-09$36000-$36.00-$52.0030.77%
2010-06-302010-07-23$7000-$52.00-$52.000%
2010-03-312010-04-30$10000-$56.82
2009-12-312010-03-19$30000-$52.00-$48.00-8.33%
2009-09-302009-12-11$7000-$52.00-$4.00-1200%
2009-06-302009-07-31$N/A-$58.40
2009-03-312009-04-30$N/A-$509.99
2008-12-312009-01-31$N/A-$308.27
2008-09-302008-10-31$N/A-$149.32
2008-06-302008-07-31$N/A-$169.04
2008-03-312008-04-30$N/A-$120.00
2007-12-312008-01-31$N/A-$98.63
2007-09-302007-10-31$N/A-$39.79
2007-06-302007-07-31$N/A-$43.99
2007-03-312007-04-30$N/A-$24.00
2006-12-312007-01-31$N/A-$38.55
2006-09-302006-10-31$N/A-$30.27
2006-06-302006-07-31$N/A-$31.16
2006-03-312006-04-30$N/A-$41.92
2005-12-312006-01-31$N/A-$44.09
2005-09-302005-10-31$N/A-$77.31
2005-06-302005-07-31$N/A-$29.09
2005-03-312005-04-30$N/A-$35.89
2004-12-312005-01-31$N/A-$44.09
2004-09-302004-10-31$N/A-$31.23
2004-06-302004-07-31$N/A-$24.96
2004-03-312004-04-30$N/A-$29.99
2003-12-312004-01-31$N/A-$49.56
2003-09-302003-10-31$N/A-$30.86
2003-06-302003-07-31$N/A-$30.54
2003-03-312003-04-30$N/A-$22.67
2002-12-312003-01-31$N/A-$31.44
2002-09-302002-10-31$N/A-$69.56
2002-06-302002-07-31$N/A-$27.11
2002-03-312002-04-30$N/A-$133.63
2001-12-312002-01-31$N/A-$32.91
2001-09-302001-10-31$N/A-$35.74
2001-06-302001-07-31$N/A-$36.46
2001-03-312001-04-30-$33.96
2000-12-312001-01-31-$27.86
2000-09-302000-10-31-$35.18
2000-06-302000-07-31-$18.58

Tenax Therapeutics, Inc (TENX) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date Sep 30 2020 Jun 30 2020 Mar 31 2020 Dec 31 2019 Sep 30 2019
Research Development N/A N/A 1.34 million N/A 916984
Income Before Tax N/A N/A -2.65 million N/A -2.22 million
Selling General Administrative N/A N/A 1.32 million N/A 1.34 million
Gross Profit N/A N/A N/A N/A N/A
Ebit N/A N/A -2.64 million N/A -2.26 million
Operating Income N/A N/A -2.67 million N/A -2.26 million
Income Tax Expense N/A N/A N/A N/A N/A
Total Revenue N/A N/A N/A N/A N/A
Cost of Revenue N/A N/A N/A N/A N/A
Total Other Income Expense Net N/A N/A 10841 N/A 36709
Net Income From Continuing Operations N/A N/A -2.65 million N/A -2.22 million
Net Income Applicable to Common Shares -2.22 million -2.15 million N/A -2.79 million -2.22 million
Cash Flow:
Date Sep 30 2020 Jun 30 2020 Mar 31 2020 Dec 31 2019 Sep 30 2019
Investments N/A N/A -6330 N/A 24105
Change to Liabilities -731730 -426461 N/A 1.38 million 219179
Total Cash Flow from Investing Activities 2692 20241 N/A -16747 24105
Net Borrowings N/A 244657 N/A N/A N/A
Total Cash Flow from Financial Activities N/A N/A 2.13 million N/A N/A
Change to Operating Activities N/A -30743 N/A -25870 -25360
Change in Cash N/A N/A -547314 N/A -1.76 million
Total Cash from Operating Activities -2.39 million -2.23 million -2.67 million -1.73 million -1.78 million
Depreciation N/A N/A 27954 N/A 27119
Other Cash Flow from Investing Activities N/A N/A N/A N/A N/A
Change to Inventory N/A N/A N/A N/A N/A
Change to Account Receivables N/A N/A -85192 N/A 114470
Other Cash Flow from Financing Activities N/A N/A N/A N/A N/A
Change to Net Income 91202 91161 N/A 62371 105956
Capital Expenditures N/A N/A N/A N/A N/A
Balance Sheet:
Date Sep 30 2020 Jun 30 2020 Mar 31 2020 Dec 31 2019 Sep 30 2019
Total Liabailities N/A N/A 2.54 million N/A 1.24 million
Total Stockholder Equity N/A N/A 3.42 million N/A 6.54 million
Other Current Liabilities N/A N/A N/A N/A N/A
Total Assets N/A N/A 5.95 million N/A 7.77 million
Common Stock 1262 1010 N/A 674 674
Other Current Assets N/A N/A N/A N/A N/A
Retained Earnings -243.19 million -240.97 million -238.82 million -236.17 million -233.38 million
Other Liabilities N/A N/A N/A N/A N/A
Other Assets 8435 8435 N/A 8435 8435
Cash N/A N/A 4.36 million N/A 6.65 million
Total Current Liabilities 1.38 million N/A 2.51 million N/A 1.13 million
Other Stockholder Equity 903 2074 N/A 458 1319
Property, Plant & Equipment 90746 119634 N/A 176007 203636
Total Current Assets 8.9 million N/A 5.8 million N/A 7.56 million
Long Term Investments N/A N/A N/A N/A N/A
Net Tangible Assets 7.4 million 3.03 million N/A 3.77 million 6.54 million
Short Term Investments N/A N/A 498535 N/A 478543
Long Term Debt N/A N/A N/A N/A N/A
Inventory N/A N/A N/A N/A N/A
Accounts Payable 1.05 million N/A 1.81 million N/A 225523

Tenax Therapeutics, Inc (TENX) Chart:

Tenax Therapeutics, Inc (TENX) News:

Below you will find a list of latest news for Tenax Therapeutics, Inc (TENX) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Tenax Therapeutics, Inc (TENX) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent

Tenax Therapeutics, Inc (TENX) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/34956/000165495420006776/0001654954-20-006776-index.htm
2018-05-22UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/34956/000000000018015768/0000000000-18-015768-index.htm
2018-11-09UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/34956/000000000018035029/0000000000-18-035029-index.htm
2020-09-04UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/34956/000000000020008381/0000000000-20-008381-index.htm
2020-02-07SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/34956/000083423720008117/0000834237-20-008117-index.htm
2020-08-07SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/34956/000083423720010111/0000834237-20-010111-index.htm
2018-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/34956/000091957418001179/0000919574-18-001179-index.htm
2020-03-23SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/34956/000091957420002542/0000919574-20-002542-index.htm
2020-07-16SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/34956/000091957420004612/0000919574-20-004612-index.htm
2020-07-163Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/34956/000091957420004613/0000919574-20-004613-index.htm
2020-07-213Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/34956/000091957420004648/0000919574-20-004648-index.htm
2020-08-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/34956/000091957420005488/0000919574-20-005488-index.htm
2020-08-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/34956/000091957420005506/0000919574-20-005506-index.htm
2020-08-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/34956/000091957420005631/0000919574-20-005631-index.htm
2020-09-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/34956/000091957420005666/0000919574-20-005666-index.htm
2020-09-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/34956/000091957420005750/0000919574-20-005750-index.htm
2018-12-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/34956/000093041318003553/0000930413-18-003553-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/34956/000093041319000506/0000930413-19-000506-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/34956/000093041320000366/0000930413-20-000366-index.htm
2019-02-12SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/34956/000103738919000081/0001037389-19-000081-index.htm
2020-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/34956/000103738920000275/0001037389-20-000275-index.htm
2017-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/34956/000114420417009009/0001144204-17-009009-index.htm
2017-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/34956/000114420417009129/0001144204-17-009129-index.htm
2018-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/34956/000114420418008998/0001144204-18-008998-index.htm
2016-11-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/34956/000118594516000005/0001185945-16-000005-index.htm
2016-12-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/34956/000118594516000006/0001185945-16-000006-index.htm
2016-11-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/34956/000135448816008600/0001354488-16-008600-index.htm
2016-12-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/34956/000135448816008683/0001354488-16-008683-index.htm
2016-12-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/34956/000135448816008686/0001354488-16-008686-index.htm
2017-03-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/34956/000135448817000426/0001354488-17-000426-index.htm
2019-02-05SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/34956/000139382519000103/0001393825-19-000103-index.htm
2017-04-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/34956/000148143617000001/0001481436-17-000001-index.htm
2017-07-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/34956/000148143617000002/0001481436-17-000002-index.htm
2018-01-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/34956/000148143618000001/0001481436-18-000001-index.htm
2018-04-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/34956/000148143618000002/0001481436-18-000002-index.htm
2018-08-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/34956/000148143618000003/0001481436-18-000003-index.htm
2017-01-06SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/34956/000153561017000010/0001535610-17-000010-index.htm
2018-01-04SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/34956/000153561018000009/0001535610-18-000009-index.htm
2016-11-293Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/34956/000165495416004381/0001654954-16-004381-index.htm
2017-01-318-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/34956/000165495417000610/0001654954-17-000610-index.htm
2017-03-1610-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/34956/000165495417002098/0001654954-17-002098-index.htm
2017-03-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/34956/000165495417002156/0001654954-17-002156-index.htm
2017-04-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/34956/000165495417003111/0001654954-17-003111-index.htm
2017-04-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/34956/000165495417003162/0001654954-17-003162-index.htm
2017-04-28DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/34956/000165495417003805/0001654954-17-003805-index.htm
2017-05-1010-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/34956/000165495417004348/0001654954-17-004348-index.htm
2017-06-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/34956/000165495417005605/0001654954-17-005605-index.htm
2017-07-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/34956/000165495417006748/0001654954-17-006748-index.htm
2017-08-0910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/34956/000165495417007141/0001654954-17-007141-index.htm
2017-09-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/34956/000165495417008379/0001654954-17-008379-index.htm
2017-11-0910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/34956/000165495417010320/0001654954-17-010320-index.htm
2017-11-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/34956/000165495417010896/0001654954-17-010896-index.htm
2017-12-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/34956/000165495417011773/0001654954-17-011773-index.htm
2017-12-29PRE 14AOther preliminary proxy statementshttps://www.sec.gov/Archives/edgar/data/34956/000165495417011940/0001654954-17-011940-index.htm
2018-01-16DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/34956/000165495418000437/0001654954-18-000437-index.htm
2018-02-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/34956/000165495418001612/0001654954-18-001612-index.htm
2018-02-238-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/34956/000165495418001818/0001654954-18-001818-index.htm
2018-03-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/34956/000165495418002520/0001654954-18-002520-index.htm
2018-04-0210-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/34956/000165495418003517/0001654954-18-003517-index.htm
2018-04-03S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/34956/000165495418003597/0001654954-18-003597-index.htm
2018-04-20DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/34956/000165495418004203/0001654954-18-004203-index.htm
2018-05-15S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/34956/000165495418005446/0001654954-18-005446-index.htm
2018-05-1510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/34956/000165495418005454/0001654954-18-005454-index.htm
2018-05-21CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/34956/000165495418005699/0001654954-18-005699-index.htm
2018-06-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/34956/000165495418006310/0001654954-18-006310-index.htm
2018-06-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/34956/000165495418006607/0001654954-18-006607-index.htm
2018-08-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/34956/000165495418009137/0001654954-18-009137-index.htm
2018-11-06S-1General form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/34956/000165495418012073/0001654954-18-012073-index.htm
2018-11-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/34956/000165495418012742/0001654954-18-012742-index.htm
2018-11-20S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/34956/000165495418013042/0001654954-18-013042-index.htm
2018-11-20FWPFiling under Securities Act Rules 163/433 of free writing prospectuseshttps://www.sec.gov/Archives/edgar/data/34956/000165495418013051/0001654954-18-013051-index.htm
2018-12-03S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/34956/000165495418013509/0001654954-18-013509-index.htm
2018-12-04CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/34956/000165495418013567/0001654954-18-013567-index.htm
2018-12-04CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/34956/000165495418013568/0001654954-18-013568-index.htm
2018-12-06S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/34956/000165495418013611/0001654954-18-013611-index.htm
2018-12-06CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/34956/000165495418013649/0001654954-18-013649-index.htm
2018-12-06CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/34956/000165495418013650/0001654954-18-013650-index.htm
2018-12-07CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/34956/000165495418013704/0001654954-18-013704-index.htm
2018-12-07CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/34956/000165495418013705/0001654954-18-013705-index.htm
2018-12-07424B4Prospectus [Rule 424(b)(4)]https://www.sec.gov/Archives/edgar/data/34956/000165495418013735/0001654954-18-013735-index.htm
2018-12-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/34956/000165495418013810/0001654954-18-013810-index.htm
2019-04-0110-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/34956/000165495419003861/0001654954-19-003861-index.htm
2019-04-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/34956/000165495419004580/0001654954-19-004580-index.htm
2019-04-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/34956/000165495419004581/0001654954-19-004581-index.htm
2019-04-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/34956/000165495419004582/0001654954-19-004582-index.htm
2019-04-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/34956/000165495419004583/0001654954-19-004583-index.htm
2019-04-19DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/34956/000165495419004596/0001654954-19-004596-index.htm
2019-04-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/34956/000165495419004651/0001654954-19-004651-index.htm
2019-05-1510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/34956/000165495419006116/0001654954-19-006116-index.htm
2019-06-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/34956/000165495419007357/0001654954-19-007357-index.htm
2019-08-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/34956/000165495419009589/0001654954-19-009589-index.htm
2019-08-30S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/34956/000165495419010209/0001654954-19-010209-index.htm
2019-11-088-K/ACurrent reporthttps://www.sec.gov/Archives/edgar/data/34956/000165495419012565/0001654954-19-012565-index.htm
2019-11-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/34956/000165495419013001/0001654954-19-013001-index.htm
2020-01-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/34956/000165495420000327/0001654954-20-000327-index.htm
2020-03-13424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/34956/000165495420002580/0001654954-20-002580-index.htm
2020-03-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/34956/000165495420002581/0001654954-20-002581-index.htm
2020-03-27DNotice of Exempt Offering of Securitieshttps://www.sec.gov/Archives/edgar/data/34956/000165495420003352/0001654954-20-003352-index.htm
2020-03-3010-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/34956/000165495420003498/0001654954-20-003498-index.htm
2020-04-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/34956/000165495420004640/0001654954-20-004640-index.htm
2020-04-29DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/34956/000165495420004643/0001654954-20-004643-index.htm
2020-05-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/34956/000165495420004979/0001654954-20-004979-index.htm
2020-05-1510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/34956/000165495420005647/0001654954-20-005647-index.htm
2020-05-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/34956/000165495420005663/0001654954-20-005663-index.htm
2020-05-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/34956/000165495420005665/0001654954-20-005665-index.htm
2020-05-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/34956/000165495420005666/0001654954-20-005666-index.htm
2020-05-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/34956/000165495420005667/0001654954-20-005667-index.htm
2020-05-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/34956/000165495420005679/0001654954-20-005679-index.htm
2020-05-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/34956/000165495420005765/0001654954-20-005765-index.htm
2020-06-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/34956/000165495420006219/0001654954-20-006219-index.htm
2020-06-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/34956/000165495420006257/0001654954-20-006257-index.htm
2020-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/34956/000165495420006645/0001654954-20-006645-index.htm
2020-06-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/34956/000165495420006776/0001654954-20-006776-index.htm
2020-07-08424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/34956/000165495420007442/0001654954-20-007442-index.htm
2020-07-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/34956/000165495420007444/0001654954-20-007444-index.htm
2020-07-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/34956/000165495420007819/0001654954-20-007819-index.htm
2020-07-22DNotice of Exempt Offering of Securitieshttps://www.sec.gov/Archives/edgar/data/34956/000165495420007918/0001654954-20-007918-index.htm
2020-08-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/34956/000165495420009183/0001654954-20-009183-index.htm
2020-08-20S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/34956/000165495420009391/0001654954-20-009391-index.htm
2020-09-11S-3/ARegistration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/34956/000165495420010005/0001654954-20-010005-index.htm
2020-09-11CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/34956/000165495420010006/0001654954-20-010006-index.htm
2020-09-29CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/34956/000165495420010605/0001654954-20-010605-index.htm
2020-10-01424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/34956/000165495420010699/0001654954-20-010699-index.htm
2020-10-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/34956/000165495420011170/0001654954-20-011170-index.htm
2020-05-18SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/34956/000178397620000008/0001783976-20-000008-index.htm
2020-06-02SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/34956/000178397620000009/0001783976-20-000009-index.htm
2018-05-23EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/34956/999999999518001328/9999999995-18-001328-index.htm
2018-12-07EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/34956/999999999518003067/9999999995-18-003067-index.htm
2020-09-30EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/34956/999999999520002631/9999999995-20-002631-index.htm

Tenax Therapeutics, Inc (TENX) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Tenax Therapeutics, Inc (TENX). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 33%
Institutional Ownership: 3215%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2018-03-30Michael B JebsenCFOSell6,425.005.4234,823.5012,310.00https://www.sec.gov/Archives/edgar/data/34956/000148143618000002/0001481436-18-000002-index.htm
2017-12-18RONALD R BLANCKDirectorBuy6,475.000.463,005.7013,624.00https://www.sec.gov/Archives/edgar/data/34956/000165495417011773/0001654954-17-011773-index.htm
2017-03-15John P KelleyChief Executive OfficerBuy213,420.001,379,931.00https://www.sec.gov/Archives/edgar/data/34956/000135448817000426/0001354488-17-000426-index.htm
2016-11-22GERALD T PROEHLDirectorBuy15,433.001.5924,538.4715,433.00https://www.sec.gov/Archives/edgar/data/34956/000135448816008600/0001354488-16-008600-index.htm
2020-08-19ARMISTICE CAPITAL, LLCDirectorBuy0.001,594,378.00https://www.sec.gov/Archives/edgar/data/34956/000091957420005488/0000919574-20-005488-index.htm
2020-08-19ARMISTICE CAPITAL, LLCDirectorBuy70,767.001.45102,612.151,594,378.00https://www.sec.gov/Archives/edgar/data/34956/000091957420005488/0000919574-20-005488-index.htm
2020-08-20ARMISTICE CAPITAL, LLCDirectorBuy0.001,718,850.00https://www.sec.gov/Archives/edgar/data/34956/000091957420005488/0000919574-20-005488-index.htm
2020-08-20ARMISTICE CAPITAL, LLCDirectorBuy124,472.001.53190,442.161,718,850.00https://www.sec.gov/Archives/edgar/data/34956/000091957420005488/0000919574-20-005488-index.htm
2020-08-21ARMISTICE CAPITAL, LLCDirectorBuy0.001,835,092.00https://www.sec.gov/Archives/edgar/data/34956/000091957420005488/0000919574-20-005488-index.htm
2020-08-21ARMISTICE CAPITAL, LLCDirectorBuy116,242.001.44167,388.481,835,092.00https://www.sec.gov/Archives/edgar/data/34956/000091957420005488/0000919574-20-005488-index.htm
2020-08-24ARMISTICE CAPITAL, LLC10% Share HolderBuy0.001,840,784.00https://www.sec.gov/Archives/edgar/data/34956/000091957420005506/0000919574-20-005506-index.htm
2020-08-24ARMISTICE CAPITAL, LLC10% Share HolderBuy5,692.001.478,367.241,840,784.00https://www.sec.gov/Archives/edgar/data/34956/000091957420005506/0000919574-20-005506-index.htm
2020-08-25ARMISTICE CAPITAL, LLC10% Share HolderBuy0.001,857,995.00https://www.sec.gov/Archives/edgar/data/34956/000091957420005506/0000919574-20-005506-index.htm
2020-08-25ARMISTICE CAPITAL, LLC10% Share HolderBuy17,211.001.5326,332.831,857,995.00https://www.sec.gov/Archives/edgar/data/34956/000091957420005506/0000919574-20-005506-index.htm
2020-08-26ARMISTICE CAPITAL, LLC10% Share HolderBuy0.001,869,995.00https://www.sec.gov/Archives/edgar/data/34956/000091957420005506/0000919574-20-005506-index.htm
2020-08-26ARMISTICE CAPITAL, LLC10% Share HolderBuy12,000.001.5018,000.001,869,995.00https://www.sec.gov/Archives/edgar/data/34956/000091957420005506/0000919574-20-005506-index.htm
2020-08-27ARMISTICE CAPITAL, LLCDirectorBuy0.001,881,995.00https://www.sec.gov/Archives/edgar/data/34956/000091957420005631/0000919574-20-005631-index.htm
2020-08-27ARMISTICE CAPITAL, LLCDirectorBuy12,000.001.5018,000.001,881,995.00https://www.sec.gov/Archives/edgar/data/34956/000091957420005631/0000919574-20-005631-index.htm
2020-08-31ARMISTICE CAPITAL, LLCDirectorBuy0.001,901,995.00https://www.sec.gov/Archives/edgar/data/34956/000091957420005631/0000919574-20-005631-index.htm
2020-08-31ARMISTICE CAPITAL, LLCDirectorBuy20,000.001.4529,000.001,901,995.00https://www.sec.gov/Archives/edgar/data/34956/000091957420005631/0000919574-20-005631-index.htm
2020-09-01ARMISTICE CAPITAL, LLCDirectorBuy0.001,931,995.00https://www.sec.gov/Archives/edgar/data/34956/000091957420005666/0000919574-20-005666-index.htm
2020-09-01ARMISTICE CAPITAL, LLCDirectorBuy30,000.001.4643,800.001,931,995.00https://www.sec.gov/Archives/edgar/data/34956/000091957420005666/0000919574-20-005666-index.htm
2020-09-02ARMISTICE CAPITAL, LLCDirectorBuy0.001,951,995.00https://www.sec.gov/Archives/edgar/data/34956/000091957420005666/0000919574-20-005666-index.htm
2020-09-02ARMISTICE CAPITAL, LLCDirectorBuy20,000.001.4729,400.001,951,995.00https://www.sec.gov/Archives/edgar/data/34956/000091957420005666/0000919574-20-005666-index.htm
2020-09-03ARMISTICE CAPITAL, LLCDirectorBuy0.001,987,995.00https://www.sec.gov/Archives/edgar/data/34956/000091957420005666/0000919574-20-005666-index.htm
2020-09-03ARMISTICE CAPITAL, LLCDirectorBuy36,000.001.3950,040.001,987,995.00https://www.sec.gov/Archives/edgar/data/34956/000091957420005666/0000919574-20-005666-index.htm
2017-12-18RONALD R BLANCKDirectorBuy6,475.000.452,881.3820,099.00https://www.sec.gov/Archives/edgar/data/34956/000165495417011773/0001654954-17-011773-index.htm
2020-09-04ARMISTICE CAPITAL, LLCDirectorBuy0.002,011,452.00https://www.sec.gov/Archives/edgar/data/34956/000091957420005750/0000919574-20-005750-index.htm
2020-09-04ARMISTICE CAPITAL, LLCDirectorBuy23,457.001.4133,074.372,011,452.00https://www.sec.gov/Archives/edgar/data/34956/000091957420005750/0000919574-20-005750-index.htm
2020-09-08ARMISTICE CAPITAL, LLCDirectorBuy0.002,019,995.00https://www.sec.gov/Archives/edgar/data/34956/000091957420005750/0000919574-20-005750-index.htm
2020-09-08ARMISTICE CAPITAL, LLCDirectorBuy8,543.001.4612,472.782,019,995.00https://www.sec.gov/Archives/edgar/data/34956/000091957420005750/0000919574-20-005750-index.htm
2016-11-21James P. MitchumDirectorSell7,000.001.5110,570.0026,000.00https://www.sec.gov/Archives/edgar/data/34956/000118594516000005/0001185945-16-000005-index.htm
2016-11-23GERALD T PROEHLDirectorBuy14,449.001.7625,430.2429,882.00https://www.sec.gov/Archives/edgar/data/34956/000135448816008600/0001354488-16-008600-index.htm
2018-07-31Michael B JebsenCFOSell5,720.006.2535,750.0034,680.00https://www.sec.gov/Archives/edgar/data/34956/000148143618000003/0001481436-18-000003-index.htm
2020-05-18RONALD R BLANCKDirectorBuy5,000.000.954,774.006,062.00https://www.sec.gov/Archives/edgar/data/34956/000165495420005765/0001654954-20-005765-index.htm
2017-07-31Michael B JebsenCFOSell54.000.6535.1068,146.00https://www.sec.gov/Archives/edgar/data/34956/000148143617000002/0001481436-17-000002-index.htm
2017-04-15Michael B JebsenCFOSell56.000.5430.2468,200.00https://www.sec.gov/Archives/edgar/data/34956/000148143617000001/0001481436-17-000001-index.htm
2016-12-19Michael B JebsenCFOSell49.002.07101.4368,256.00https://www.sec.gov/Archives/edgar/data/34956/000118594516000006/0001185945-16-000006-index.htm
2017-12-29Michael B JebsenCFOSell98.000.4342.1468,264.00https://www.sec.gov/Archives/edgar/data/34956/000148143618000001/0001481436-18-000001-index.htm
2017-11-14RONALD R BLANCKDirectorSell12,950.000.395,050.507,149.00https://www.sec.gov/Archives/edgar/data/34956/000165495417010896/0001654954-17-010896-index.htm